June 10, 2020 / 2:43 PM / 22 days ago

BRIEF-Corline Biomedical: Results Of First Study Of Drug Candidate Renaparin

June 10 (Reuters) - Corline Biomedical AB:

* DRUG CANDIDATE RENAPARIN SHOWS GOOD SAFETY PROFILE IN FIRST STUDY ON PATIENTS

* RENAPARIN HAS GOOD RESULTS FOR BOTH PRIMARY AND SECONDARY PHASE 1 ENDPOINTS

* NEXT STEP IN DEVELOPMENT OF RENAPARIN EXPECTED TO BE COMMUNICATED IN SEPTEMBER 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below